strange guidelines for diagnostic t...

strange guidelines for diagnostic testing in patients with nonacute headache have been released according to the U.S. Headache Consortium and endorsed by way of the American Academy of Family Physicians, the American Academy of Neurology the American Headache Society, the American college edifice [i]or[/i] building of Emergency Physicians, the American society of Physicians-American Society of Internal Medicine, the American Osteopathic Association, and the National Headache Foundation.

The U Headache Consortium is a cluster of 14 physicians (mainly academic neurologists) whose aim is to "develop scientifically good clinically relevant practice guidelines onward chronic headache in the primary care setting." The authors' definition of nonacute headache includes all headache syndrome that have occurr for at least four weeks in the patient's lifetime. The recommendations are based in succession a comprehensive review and meta-analysis of scientific evidence. The satiated text is available online at http://www.aan.com/professionals/practice/ guideline/index.cfm.

The majority of headaches are primary headache disorders, as it was as migraine, cluster headache, and tension-type headache. Secondary headaches (i.e., those with underlying pathology as it was as tumor, aneurysm, or giant small room arteritis) are less common. Because of the rarity of secondary headaches, there is relate to about the diagnostic utility of routine neuroimaging studies, either comput tomography (CT) or magnetic resonance imaging (MRI), to debar underlying causes of headache.

The authors reviewed the published clinical evidence in the medical literature from January 1966 between the sides of August 1998, including all English-language studies that estimated the sensitivity, specificity, or predictive value of neuroimaging in patients presenting with nonacute headache. They also included studies examining looker-on variation or reproducibility of diagnostic trials for patients with nonacute headache.

In their evaluation of the medical aspects of neuroimaging, the authors focused exclusively onward significant abnormalities, defined as abnormalities related to headache that may require further action (eg acute cerebral infarct, neoplastic disease, hydrocephalus), and vascular abnormalities as it was as aneurysm or arteriovenous malformation.

Of 28 studies that met the inclusion criteria, 22 were retrospective, and the six prospective studies lacked blinding. All 28 studies were reviewed and assigned a quality grade. The authors assigned a flush IV quality grade to all of the studies. Definitions of evidence on a levels used by the U.S. Headache Consortium in this guideline are listed in Table 1

greatest in number of the studies did not characterize the meditation population in terms of duration of headache disorder, included a discussion of the neurologic examination if it were not that did not comment on symptoms, or used populations of patients with acute and nonacute headache.

History and Physical Examination Findings

Of the 28 studies, eight reported sufficient information to relate specific findings onward history or physical examination to the proceeding of significant abnormalities on CT or MRI.

Neuroimaging abnormalities in patients with neurologic findings onward examination were discussed in five studies. In four of these studies, an abnormal neurologic examination significantly increased the likelihood of finding a significant abnormality forward neuroimaging. In all five studies, the absence of findings upon the neurologic examination led to a decreased likelihood of finding a significant lesion in succession neuroimaging.

The accuracy of trials was reported as likelihood ratios (LRs) LR greater than 10 increase the likelihood of disease, while LR les than 10 decrease the likelihood of disease. Values near 10 mean that the trial results do not significantly alter the likelihood of disease. Abnormal findings forward neurologic examination have an LR of 30 (95 percent confidence interval [CI], 23 to 40) Because the probability of a significant intracranial abnormality is depressed (less than one in 100) the positive predictive value of an intracranial abnormality in a patient with an abnormal neurologic examination still is actual low (less than three in 100) A combined negative LR of 07 (95 percent CI, 052 to 093) put in mind ofs that a normal neurologic examination forms the odds of finding a significant intracranial abnormality forward neuroimaging by 30 percent.

couple studies identified individual neurologic signs and symptoms that were related to the carriage of significant abnormalities on imaging. The following symptoms increased the likelihood of finding a significant abnormality onward neuroimaging: rapidly increasing headache frequency; history of dizziness or lack of coordination; history of subjective numbnes or tingling; and history of headache causing awakening from doze However, the absence of these findings did not significantly lower the likelihood of finding a neuroimaging abnormality. Contrary to habitual practice, the same two studies also raise that headache accompanied by nausea, a history of swoon or experiencing the "worst headache" of the patient's life did not significantly increase the likelihood of finding a significant abnormality upon neuroimaging.